3164 — Genmont Biotech Share Price
0.000.00%
Last trade - 00:00- TWD1.67bn
- TWD1.49bn
- TWD385.37m
- 67
- 38
- 29
- 41
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.24 | ||
| Price to Tang. Book | 1.24 | ||
| Price to Free Cashflow | 21.07 | ||
| Price to Sales | 4.36 | ||
| EV to EBITDA | 13.36 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.59% | ||
| Return on Equity | 4.29% | ||
| Operating Margin | 10.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 325.19 | 427.93 | 368.55 | 318.01 | 385.37 | n/a | n/a | 2.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -13.42 | +103.89 | -48.2 | -42.48 | +74.45 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
GenMont Biotech Incorporation is a Taiwan-based company principally engaged in the manufacture and distribution of functional lactobacillus. The Company's major products include lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus casei, lactobacillus plantarum, lactobacillus fermentum, lactobacillus salivarius, lactobacillus acidophilus, lactobacillus reuteri, lactobacillus brevis, lactobacillus bulgaricus, lactobacillus gasseri, lactobacillus johnsonii and others. The Company’s products are applied to enhance human immunity against dust allergy and digestive system health care. The Company distributes its products in domestic market and to overseas markets.
Directors
- Gende Chen CHM
- Weimin Chen COO
- Yujin Chen DGM
- Shikun Chen DRC
- Guojie Huang DRC
- Yixiong Lin DRC
- Dehui Yang DRC
- Chuanzhen Zhuo DRC
- Zhibin Gao IND
- Zeren Huang IND
- Jyh-Feng Lu IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 6th, 2000
- Public Since
- June 12th, 2003
- No. of Employees
- 147
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 86,511,000
- Address
- No.8, Tainan Science-Based Industrl Prk, TAINAN, 741
- Web
- https://www.genmont.com.tw/
- Phone
- +886 65052151
- Auditors
- KPMG LLP
Upcoming Events for 3164
Similar to 3164
AGV Products
Taiwan Stock Exchange
Charoen Pokphand Enterprise Taiwan Co
Taiwan Stock Exchange
Dawushan Farm Technology Co
Taiwan Stock Exchange
Formosa Oilseed Processing Co
Taiwan Stock Exchange
Fwusow Industry Co
Taiwan Stock Exchange
FAQ
What is the Genmont Biotech share price?
As of Today at 20:47 UTC, shares in Genmont Biotech are trading at TWD19.40. This share price information is delayed by 15 minutes.
How has the Genmont Biotech share price performed this year?
Shares in Genmont Biotech last closed at TWD19.40 and the price had moved by -12.42% over the past 365 days. In terms of relative price strength the Genmont Biotech share price has underperformed the FTSE Developed Asia Pacific Index by -11.41% over the past year.
What are the analyst and broker recommendations for Genmont Biotech?
There is no consensus recommendation for this security.
Find out moreWhat is the Genmont Biotech dividend yield?
The Genmont Biotech dividend yield is 4.12% based on the trailing twelve month period.
Does Genmont Biotech pay a dividend?
Last year, Genmont Biotech paid a total dividend of TWD0.80, and it currently has a trailing dividend yield of 4.12%.Looking ahead, the next dividend pay date is 2025-04-29.
When does Genmont Biotech next pay dividends?
We do not have data on when Genmont Biotech is to next pay dividends. The historic dividend yield on Genmont Biotech shares is currently 4.12%.
How do I buy Genmont Biotech shares?
To buy shares in Genmont Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Genmont Biotech?
As of the previous close price of TWD19.40, shares in Genmont Biotech had a market capitalisation of TWD1.67bn.
Where are Genmont Biotech shares listed?
Here are the trading details for Genmont Biotech:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 3164
What kind of share is Genmont Biotech?
Based on an overall assessment of its quality, value and momentum Genmont Biotech is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Genmont Biotech share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Genmont Biotech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genmont Biotech. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -5.92%.
As of the last closing price of TWD19.40, shares in Genmont Biotech were trading -9.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Genmont Biotech PE Ratio?
The Genmont Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD19.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Genmont Biotech?
Genmont Biotech's management team is headed by:
- Gende Chen - CHM
- Weimin Chen - COO
- Yujin Chen - DGM
- Shikun Chen - DRC
- Guojie Huang - DRC
- Yixiong Lin - DRC
- Dehui Yang - DRC
- Chuanzhen Zhuo - DRC
- Zhibin Gao - IND
- Zeren Huang - IND
- Jyh-Feng Lu - IND